HOE-234, a second generation K+ channel opener, antagonizes the ATP- dependent gating of cardiac ATP-sensitive K+ channels

A Terzic, A Jahangir and Y Kurachi

Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota.

Effects of (3S,4R)-3-hydroxy-2,2-dimethyl-4-(2-oxo-1-pyrrolidinyl)-6- phenylsulfonylchroman hemihydrate (HOE-234), a novel dilator of bronchial and vascular smooth muscles, were examined on whole-cell and single channel currents in guinea pig cardiomyocytes. Under the whole- cell voltage-clamp condition, HOE-234 (0.6-100 microM) induced a time- independent K(+)-dominant current in atrial and ventricular myocytes. This current was inhibited by glyburide, a selective blocker of ATP- sensitive K+ (KATP) channels, suggesting that HOE-234 activates KATP channels. Neither intracellular acidification nor the absence of intracellular ADP inhibited the ability of HOE-234 to induce the current. In inside-out membrane patches in the presence of 200 microM ATP, HOE-234 (0.3-10 microM) increased concentration dependently (EC50 approximately 1 microM) the KATP channel activity. In the absence of HOE-234, half-inhibition of spontaneously operative KATP channels occurred at 25 microM of intracellular ATP (ATPi), whereas in the presence of HOE-234 (10 microM), 316 microM of ATPi was required for half-inhibition. In ATP-free internal solution, KATP channels appeared and then ran down. In the absence of ATPi, HOE-234 did not increase channel activity when channels were in a fully open or in the partially or completely run-down state. After run-down, the nucleoside diphosphate, UDP, restored KATP channel activity which was not further augmented by HOE-234. However, HOE-234 relieved at ATP- or ATP gamma S- mediated inhibition of the UDP-induced KATP channel activity.(ABSTRACT TRUNCATED AT 250 WORDS)

Volume 268, Issue 2, pp. 818-825, 02/01/1994
Copyright © 1994 by American Society for Pharmacology and Experimental Therapeutics

This article has been cited by other articles:

				G. E. Billman, M. S. Houle, H. C. Englert, and H. Gogelein J. Pharmacol. Exp. Ther., April 1, 2004; 309(1): 182 - 192. [Abstract] [Full Text]

				M. BIENENGRAEBER, A. E. ALEKSEEV, M. R. ABRAHAM, A. J. CARRASCO, C. MOREAU, M. VIVAUDOU, P. P. DZEJA, and A. TERZIC ATPase activity of the sulfonylurea receptor: a catalytic function for the KATP channel complex FASEB J, October 1, 2000; 14(13): 1943 - 1952. [Abstract] [Full Text]

				H. Gögelein, J. Hartung, H. C. Englert, and B. A. Schölkens HMR 1883, a Novel Cardioselective Inhibitor of the ATP-Sensitive Potassium Channel. Part I: Effects on Cardiomyocytes, Coronary Flow and Pancreatic beta -Cells J. Pharmacol. Exp. Ther., September 1, 1998; 286(3): 1453 - 1464. [Abstract] [Full Text]

				A. Shinbo, K. Ono, and T. Iijima Activation of Cardiac ATP-Sensitive K+ Channels by KRN4884, a Novel K+ Channel Opener J. Pharmacol. Exp. Ther., November 1, 1997; 283(2): 770 - 777. [Abstract] [Full Text]